November 12, 2009 (FinancialWire) — Bioheart, Inc. (OTCBB: BHRT) has elected Lee Jones to its board. Jones, who will serve as an independent director on Bioheart’s board, has been the chief administrative officer of the Schulze Diabetes Institute at the University of Minnesota since June 2009.

Jones served from 1997 to 2005 as president and chief executive officer of Inlet Medical, which specializes in minimally interventional laparoscopic products.

Prior to joining Inlet, she had a 14-year career at Medtronic, where she held various technical and operating positions, most recently serving as director and general manager of the company’s urology and interstim division.

The addition of Jones brings the Bioheart board’s membership to eight.

Sunrise, Florida-based Bioheart offers devices and biologics used to help monitor, diagnose and treat heart failure and cardiovascular diseases.

The company’s lead product candidate, MyoCell, is a clinical muscle-derived stem cell therapy designed to populate regions of scar tissue within a patient’s heart with new living cells for the purpose of improving cardiac function in chronic heart failure patients.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.